genOway

Historical price data

genOway's mission is to accelerate and de-risk therapeutic development by providing highly predictive, genetically engineered preclinical models. The company has established itself as a critical enabler in the research supply chain, with a client base that includes 17 of the top 20 pharmaceutical companies, over 170 biotechs, and 380 academic institutions across 28 countries. Its strategy centers on expanding its catalog of validated, off-the-shelf models while offering deep customization services, leveraging its proprietary genetic engineering platforms to support the entire preclinical workflow from target validation to safety assessment.

Proprietary genetic engineering platform for creating 'humanized' preclinical mouse, rat, and cellular models, including the foundational genO-BRGSF immunodeficient strain, target-specific humanized models, and double/multi-humanized models for complex biology.

Competes with large, full-service CROs (e.g., Charles River) on specialization and with niche model providers (e.g., Taconic, Jackson Lab) on proprietary humanization technology. Key advantages include the genO-BRGSF platform, deep client relationships, and strong scientific validation through publications.